Cargando…

Linagliptin versus sitagliptin in patients with type 2 diabetes mellitus: a network meta-analysis of randomized clinical trials

BACKGROUND: Diabetes is one of the most common chronic and costly diseases worldwide and type 2 diabetes is the most common type which accounts for about 90% of cases with diabetes. New medication-therapy regimens such as those containing linagliptin alone or in combination with other medications (w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keshavarz, Khosro, Lotfi, Farhad, Sanati, Ehsan, Salesi, Mahmood, Hashemi-Meshkini, Amir, Jafari, Mojtaba, Mojahedian, Mohammad M., Najafi, Behzad, Nikfar, Shekoufeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655990/ https://www.ncbi.nlm.nih.gov/pubmed/29070077 http://dx.doi.org/10.1186/s40199-017-0189-6

Ejemplares similares

Social accounting matrix and the effects of economic reform on health price index and household expenditures: Evidence from Iran
por: Keshavarz, Khosro, et al.
Publicado: (2017)

Evaluation of the effectiveness of infusion of bone marrow derived cell in patients with heart failure: A network meta-analysis of randomized clinical trials and cohort studies
por: Lotfi, Farhad, et al.
Publicado: (2020)

Pharmacists Remuneration Models in Iran and Selected Countries: a Comparative Study
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2013)

A Cost-Utility Analysis of Different Antiviral Medicine Regimens in Patients With Chronic Hepatitis C Virus Genotype 1 Infection
por: Alavian, Seyed Moayed, et al.
Publicado: (2016)

Financial perspective of private pharmacies in Tehran (Iran); is it a lucrative business?
por: Keshavarz, Khosro, et al.
Publicado: (2012)

A systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experience
por: Keshavarz, Khosro, et al.
Publicado: (2013)

Is Taurolidine-citrate an effective and cost-effective hemodialysis catheter lock solution? A systematic review and cost- effectiveness analysis
por: Kavosi, Zahra, et al.
Publicado: (2016)

Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma: a systematic review and meta-analysis
por: Goudarzi, Zahra, et al.
Publicado: (2023)

Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancer
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2013)

A Cost-Utility and Cost-Effectiveness Analysis of Different Oral Antiviral Medications in Patients With HBeAg-Negative Chronic Hepatitis B in Iran: An Economic Microsimulation Decision Model
por: Keshavarz, Khosro, et al.
Publicado: (2016)

Positron Emission Mammography (PEM) in the diagnosis of breast cancer: A systematic review and economic evaluation
por: Keshavarz, Khosro, et al.
Publicado: (2020)

Evaluation of COVID-19 Treatments in Iran in Comparison with Local Therapeutic Recommendations: A Population-Level Study on Utilization and Costs of Prescription Drugs
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2022)

Tenecteplase Versus Reteplase in Acute Myocardial Infarction: A Network Meta-Analysis of Randomized Clinical Trials
por: Zia-Behbahani, Majid, et al.
Publicado: (2019)

Pegylated versus non-pegylated interferon beta 1a in patients with relapsing-remitting multiple sclerosis: A cost-effectiveness analysis
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2018)

COVID-19 Reinfection Rate and Related Risk Factors in Fars Province, Iran: A Retrospective Cohort Study
por: Tavakoli, Ali, et al.
Publicado: (2023)

Assessment of the vaccine industry in Iran in context of accession to WTO: a survey study
por: Hashemi Meshkini, Amir, et al.
Publicado: (2012)

From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2014)

Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2023)

A review on inputs and outputs in determining the efficiency of universities of medical sciences by data envelopment analysis method
por: Mojahedian, Mohammad M., et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Topiramate versus Phenobarbital in the Treatment of Children with Febrile Seizure
por: NEMATI, Hamid, et al.
Publicado: (2019)

Economic burden of major depressive disorder: a case study in Southern Iran
por: Keshavarz, Khosro, et al.
Publicado: (2022)

Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes
por: Messori, Andrea, et al.
Publicado: (2014)

Economic Burden of Hepatitis B Virus-Related Diseases: Evidence From Iran
por: Keshavarz, Khosro, et al.
Publicado: (2015)

A novel model-based meta-analysis to indirectly estimate the comparative efficacy of two medications: an example using DPP-4 inhibitors, sitagliptin and linagliptin, in treatment of type 2 diabetes mellitus
por: Gross, Jorge Luiz, et al.
Publicado: (2013)

The impact of cytomegalovirus infection on new-onset diabetes mellitus after kidney transplantation: a review on current findings
por: Einollahi, Behzad, et al.
Publicado: (2014)

Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus
por: Retlich, Silke, et al.
Publicado: (2015)

An open-label pilot study on preventing glucocorticoid-induced diabetes mellitus with linagliptin
por: Miyawaki, Yoshia, et al.
Publicado: (2018)

Challenges of access to medicine and the responsibility of pharmaceutical companies: a legal perspective
por: Ahmadiani, Saeed, et al.
Publicado: (2016)

Making the Public Health and Industrial Objectives Balanced; the Big Challenge of Iran’s Food and Drug Organization
por: HASHEMI-MESHKINI, Amir
Publicado: (2014)

The Effect of Linagliptin versus Metformin Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus
por: Mita, Tomoya, et al.
Publicado: (2018)

Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent
por: Tang, Yun-Zhao, et al.
Publicado: (2015)

Targeting DPP4-RBD interactions by sitagliptin and linagliptin delivers a potential host-directed therapy against pan-SARS-CoV-2 infections
por: Mani, Shailendra, et al.
Publicado: (2023)

The clinical application of linagliptin in Asians
por: Cao, Chu-qing, et al.
Publicado: (2015)

Linagliptin: from bench to bedside
por: Doupis, John
Publicado: (2014)

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus
por: Miller, Shannon A, et al.
Publicado: (2009)

Sitagliptin improves albuminuria in patients with type 2 diabetes mellitus
por: Mori, Hiroko, et al.
Publicado: (2013)

Atypical medulloblastoma: A case series
por: Meshkini, Ali, et al.
Publicado: (2014)

Pharmaceutical market and health system in the Middle Eastern and Central Asian countries: Time for innovations and changes in policies and actions
por: Abdollahias, Akbar, et al.
Publicado: (2011)

The place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysis
por: Rezaie, Ali, et al.
Publicado: (2010)

Are probiotics effective in management of irritable bowel syndrome?
por: Hosseini, Asieh, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kj1mp1j8i6bvtuaq2ij1a460l5